secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2026-05-21T20:10:03+00:00
Accession:  0001438133-26-000070
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 3.03, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes shareholders approve charter amendments and equity plan increase at annual meeting
--------------------------------------------------------------------------------

- Shareholders approved charter amendments to allow removal of directors with or without cause and limit officer liability per DGCL Sections 141(k) and 102(b)(7).
- 2023 Long-Term Incentive Plan amended to increase authorized shares by 3,260,000, bringing total to 8,862,184 shares.
- All nine director nominees elected; Christopher Twomey received 7,034,208 against votes (12.8% of votes cast) but still passed.
- Say-on-pay passed with 53,460,747 for, 1,481,027 against.
- Ernst & Young ratified as independent auditor for fiscal year ending December 31, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813326000070/0001438133-26-000070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813326000070/tndm-20260520.htm
  HTML page:      https://secwatch.observer/filing/0001438133-26-000070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer